Source: International Congress 2014 – COPD: points to ponder
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Konopkina, B. Basina (Dnipropetrovsk, Ukraine). Individual dynamic of inflammatory markers as indicators of COPD treatment effectiveness. Eur Respir J 2014; 44: Suppl. 58, 3634

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Clinical, functional and laboratory assessment of treatment efficacy in COPD patients Source: International Congress 2014 – Predictors Year: 2014 Features of systemic inflammation in patients with stable COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Functional Respiratory Imaging as a sensitive biomarker to assess therapeutic interventions in lung diseases Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016 Scales of assesment in COPD. Correlation with clinical and functional parameters Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Paradoxical response to bronchodilators: Radiologic correlates and clinical implications Source: International Congress 2014 – Modern approach and old dilemmas in lung diseases Year: 2014 Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis Source: International Congress 2014 – COPD exacerbations Year: 2014 Relation of plasma osteopontin levels with the clinical course in patients with COPD Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Can red blood cell morphology be an indicator for COPD exacerbations? Source: International Congress 2014 – Markers Year: 2014 Changes in inhalation therapy after combined assessment of COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis Source: International Congress 2016 – Active and latent tuberculosis: biomarkers Year: 2016 Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014 The role of COPD in development of osteoporosis Source: International Congress 2014 – Markers Year: 2014 Pharmacological treatment of COPD in the on-sint cohort Source: International Congress 2014 – COPD exacerbations Year: 2014 Adrenomedullin optimizes mortality prediction in COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 A multimarker approach to identify atherosclerosis in COPD Source: International Congress 2014 – Markers Year: 2014 Laboratory and clinical parameters in predicting risk of future exacerbations in both non-smoking and smoking COPD patients Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014